WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

MELAS - AN EVIDENCE BASED TREATMENT MODALITY

*Dr. Rajesh Shankar Iyer, Dr. Josy J Vallippalam, Nitya Suresh and Saloni Krishna

ABSTRACT

MELAS syndrome is a multi-organ disease with broad manifestations including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Management is largely symptomatic and are based on the use of antioxidants, respiratory chain substrates and cofactors in the form of vitamins. Some of the most frequently prescribed agents include coenzyme Q10, L-arginine, B vitamins, and levocarnitine.

Keywords: MELAS syndrome, Coenzyme Q10, L-Arginine.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More